(R)-1-(3,4-Difluorophenyl)ethanamine is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of active pharmaceutical ingredients (APIs). Its enantiomeric purity makes it valuable in the development of drugs that require specific stereochemistry for efficacy, particularly in central nervous system (CNS) therapeutics. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other psychoactive compounds, where the (R)-configuration is critical for binding to biological targets. Additionally, it serves as an intermediate in the synthesis of agrochemicals, contributing to the creation of pesticides and herbicides with enhanced activity and selectivity. Its role in asymmetric synthesis also extends to the preparation of fine chemicals and specialty materials.